prime health glp-1 reviews continues to lead industry on research: 1 in 7 stays on GLP-1 drugs for weight loss after two years - Prime Therapeutics PrimeHealth - Weight loss, simplified

10.1097/gox.0000000000005747 19 BrownS.MehraraB

concurrent GLP-1 use may further reduce appetite-driven caloric excess and support more sustainable weight loss in this subgroup

A newer development is the oral semaglutide pill (Rybelsus for diabetes, and the recently approved oral Wegovy), which brings the same active ingredient in tablet form

The Weight Loss + Labs plan is $668 per vial and includes a provider call, two in-home nurse visits, 7 to 10 semaglutide injections, and a blood draw with lab work

Here is the concern

Higher doses of elecoglipron increased the likelihood that participants would lose significant weight